Early studies on DNA-based immunizations for measles virus

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Measles virus poses a significant global health challenge, necessitating effective vaccine strategies.
• DNA-mediated immunization offers a novel approach for generating immune responses against viral pathogens.

Purpose of the Study:

• To evaluate the efficacy of DNA vaccines encoding measles virus hemagglutinin (HA) and fusion (F) glycoproteins in eliciting neutralizing antibodies.
• To assess the duration and effectiveness of the antibody response generated by DNA immunization.

Main Methods:

• BALB/c mice and rabbits were inoculated with plasmids expressing measles virus HA and F glycoproteins.
• Neutralizing antibody titers were measured following immunization.
• The effectiveness of antibodies was assessed by comparing neutralizing activity to ELISA activity.

Main Results:

• Single inoculations with plasmids encoding HA or F glycoproteins successfully raised neutralizing antibodies in mice.
• Neutralizing antibody responses in mice, particularly from HA-expressing plasmids, persisted for up to one year.
• Both normal and secreted forms of HA-expressing plasmids induced comparable antibody effectiveness.
• High titers of neutralizing antibodies were also achieved in rabbits immunized with HA and F glycoprotein-expressing plasmids.

Conclusions:

• DNA-mediated immunization is a viable strategy for generating neutralizing antibodies against measles virus.
• Measles virus glycoprotein-expressing DNA vaccines can induce persistent and effective antibody responses.
• This approach holds promise for the development of new measles vaccine candidates.